Masimo (NASDAQ: MASI) Announces Findings of Study Investigating Masimo Root

Masimo Corporation (NASDAQ: MASI) has disclosed that the results of the study examining whether Masimo Root with a multimodal brain monitoring algorithm copes with anesthesia during spinal surgery could enhance postoperative cognitive function. This is the first study of this kind and the discoveries of a potential study issued in Frontiers in Aging Neuroscience in which Dr. Shuyi Yang and colleagues at Capital Medical University in Beijing examined Masimo Root together.

It has been discovered that perioperative neurocognitive disorder (PND) is common in elderly patients experiencing surgery and that PND has been linked with levels of sedation, analgesia, and cerebral oxygen saturation. The examiner attempted to assess whether the use of an algorithm conceived around related parameters might help enhance this population’s postoperative neurocognition.

Results of the Study

The examiner discovered that managing anesthesia based on the multimodal algorithm may enhance the postoperative cognitive function and brain functional connectivity in elderly patients enduring spinal surgery compared to routine anesthesia management. In the study, the algorithm combined measurements from Root, comprising Masimo SedLine Brain Function Monitoring, Masimo O3 Regional Oximetry, and ANI Analgesia Nociception Index.

Furthermore, the scope of postoperative systemic inflammation was negatively linked with the FC enhancement and may be complemented by a lower MoCA score. The discoveries provide a basis for more effective management of elderly patients who undertake surgery to decrease the risk of cognitive disorders and enhance brain function.

Additionally, this was a well-applied study, and while it may have been small, it has large effects regarding the value of precision monitoring during surgery and with the potential for application in the intensive care unit (ICU). This may signify a vital advance in the prevention of PND and also the prevention of delirium in ICU patients. Moreover, larger studies will be necessary to confirm these initial data.